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In the past three decades a large amount of
evidence has accumulated which indicates that
viable mononuclear blood cells and lymph node
cells in guinea pigs contain the factor which is
responsible for allergic contact-type sensitivity.
Landsteincr and Chase were successful in induc-
ing skin sensitivity in normal guinea pigs by the
intraperitoneal injection of cells from peritoneal
exudates of guinea pigs rendered sensitive to
simple compounds (1,2,3). Subsequently, Hax-
thausen (4) and others have accomplished pas-
sive transfer of allergic contact sensitivity using
similar technics in guinea pigs.
rile results of passive transfer studies with
cells in allergic eczcmatous contact dermatitis
in man, however, have been contradictory.
Haxthausen reported negative results in passive
transfer experiments using viable white blood
cells (5) and cells from freshly excised lymph
nodes (6). Passive transfer tests with viable
white blood cells were interpreted as negative by
Baer and Sulzbcrger (7), and by Baer, Scrri and
Kirman (8). Epstein and Kligman (9) reported
successful passive transfer of eczematous sensi-
tivity to three contact allergens in man: 3-penta-
decylcatechol [PDCJ, paranitrosodimcthylaniline
[NDMA] and 2: 4-dinitrochlorobenzene [DNCBI
by the use of blister fluid, of white blood cell
suspensions and of whole blood transfusions.
Successful passive transfers also were reported
by Good and Zak (10) and Kcrp and Koprowski
(11). Harbcr and Bacr (12), however, were
unable to demonstrate passive transfer of aller-
gic eczematous contact sensitivity to DNCB
using the technic of whole blood transfusions.
The present study was undertaken with the
possibility in mind that if the mononuclear
white blood cells in man carry the factor which
mediates cczematous contact allergy, the intra-
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cutaneous injection of autologous white blood
cells in patients with a strong allergic contact
sensitivity might cause an at least temporary
increase in sensitivity at the site of injection.
METnons ANO MATERIALS
The tests were carried out in twenty-five
patients who were known to have strong (3 to 4+)
reactions to standard patch test concentrations of
commonly encountered contact allergens. Quan-
titative patch tests were performed in those
patients with dilutions of the standard patch
test concentration of the allergen to which they
were known to be sensitive. On the basis of the
results of these tests an attempt was made to
select for further testing three or four concentra-
tions which were above, at and just below the
threshold of reactivity.
Suspensions of viable white blood cells were
prepared using the method of Friedman ci at
(13) as follows: approximately 27.5 cc of venous
blood was drawn into a 30 cc glass syringe contain-
ing 10 mg of heparint and 400 mg of dextran
(2 cc of a 20% aqueous autoclaved solution).
The needle then was occluded by insertion into a
disposable needle container, and the syringe was
placed in the refrigerator at 4° C, resting on the
plunger in a vertical position. After 15 to 60
minutes in this position two distinct layers
appeared: a lower layer of sedimented red cells
and an upper straw-colored layer of leukocytes
and platelets suspended in plasma. The upper
straw-colored layer was expressed into a centrifuge
tube by maintaining the syringe in vertical posi-
tion, applying pressure to the plunger, and forcing
the fluid through the needle bent at a right angle.
Ten to 15 cc of straw-colored material which is
usually obtained by this procedure, was then
centrifuged at approximately 2000 rpm for ten
minutes in order to separate the leukocytes. The
plasma was pipetted off until oaly 1 cc remained
in the tube; this remaining plasma was then
thoroughly mixed with the leukocyte button to
produce a homogeneous leukocyte suspension,
which was used for intracutaneous injection.
Cell-free plasma was nsed as a control.
Smears of the white blood cell fraction showed
white blood cells of both granulocytic and lympho-
cytic series with a normal differential count and
t Liquaemin Sodium, Organon, Inc., Orange,
New Jersey.
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TABLE I
Reactions to patch tests applied immediately after intracutaneous injections of autologous white blood cells
Concentrations of Allergens
48-Hour Patch Test Readings
WBC injected
sites
Plasma injected
sites
Unprepared
sites
M. T. Ethylamino benzoate in Petrolatum:
1/40% + ++ +++
1/100% 0 0 +++
1/200% 0 0 ++
1/1000% 0 0 +
H. C. Nickel sulfate aq. sol.:
1/5% ++ ++ ++
1/25% + + ++
1/125% + + 0
1/625% 0 0 0
F. P. Pentadecylcatechol in Acetone:
1/100% +++ +++ ++
1/1000% 0 0 0
1/10000% 0 0 0
1/20000% 0 0 0
A. M. Potassium dichromate aq. sol.:
1/25% ++ ++ ++
1/125% + + ++
1/625% 0 + +
1/3125% 0 0 0
F. J. Mercury bichloride aq. sol.:
1/100% Delayed reaction 0 +
1/200% to cells at all 0 0
1/1000% sites 0 0
1/10000% 0 0
W. A. Mercury bichloride aq. so!.:
1/20% ++ ++ +++
1/100% + + ++
1/500% 0 0 0
1/1000% 0 0 0
E. F. Tetra methyl thiuram disulfide in Petro-
latum:
1/2% +++ +++ ++++
1/4% +++ +++ +++
1/10% ++ ++ ++
1/20 0 0 0
J. C. Potassium dichromate aq. sol.:
1/10% Delayed reaction + ++
1/25% to cells at all 0 0
1/125% sites 0 0
1/625% 0 0
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TABLE I—Continued
Concentrations of Allergens
48-Hour Patch Test Readings
WBC injected
sites
Plasma injected
sites Unpreparedsites
A. H. Paraphenylenediamine in Petrolatum:
1/4% ++ +++ +++
1/10% + + ++
1/20% + + ++
1/100% 0 0 +
M. H. Nickel sulfate aq. so!.:
++++ ++++ ++++
2% ++ ++ ++
1% 0 0 0
1/2% 0 0 0
B. A. Potassium dichromate aq. so!.:
1/10% ++ 0 ++
1/25% 0 0 0
1/125% 0 0 +
1/625% 0 0 0
F. S. Nickel sulfate aq. so!.:
1/2% ++ ++ +++
1/5% + ++ ++
1/25% 0 0 +
1/125% 0 0 0
J. G. Poison ivy, Oleoresin (Graham Labs):
1% + +++ +++
1/10% + 0 0
1/100% + 0 0
1/1000% 0 0 0
A. D. Paraphenylenediamine in Petrolatum:
1/10% +++ +++ +++
1/20% ++ +++ ++
1/40% ++ ++ ++
1/100% + + +
A. S. Potassium dichromate aq. sot.:
1/5% ++ +++ +++
1/10% ++ ++ ++
1/25% 0 0 0
1/125% 0 0 0
S. L. Paraphenylenediamine in Petrolatum:
1/10% ++ +++ ++
1/20% + ++ ++
1/40% + + ++
1/100% + + +
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the presence of platelets. As was to be expected
with this technic, there were considerable varia-
tions in the number of white blood cells per cubic
millimeter between different specimens; the range
being 20,000 to 240,000 white blood cells/cubic
millimeter.
Immediately after preparation, the autologous
leukocyte suspension was injected intra-
cutaneously into 3 or 4 sites on the flexor surface
of the forearm of the patient at intervals of
approximately five centimeters. Using a tuberculin
syringe and *'25 needle, 0.15 cc was injected per
site in 16 subjects, 0.2 cc per site in 5 subjects
and 0.4 cc per site in 4 subjects. Control sites on
the contralateral forearm were injected in an
identical fashion with autologous plasma. Except
in 2 subjects these injections, as expected (11),
did not produce a clinically evident cutaneous
reaction after 24 to 72 hours. Immediately or 24,
48 or 72 hours after these injections, quantitative
patch tests with the homologous allergen were
performed at these sites as well as at control sites
injected with plasma and at unprepared control
sites.
RESULTS
Sixteen patients were patch tested immedi-
ately following intracutaneous injectioa. The
results in this group are given in Table I. Many
of the subjects showed slightly diminished patch
test reactions at sites injected with autologous
white blood cells, as compared with sites injected
with autologous plasma. This difference was even
TABLE II
Reactions to petch tests applied 24 hours efter
intracutaneous injections of autologous
white blood cells
Concentrations
of Allergens
48-Hour Patch Test
Readings
ABC Plasma Unpre-
injected injected pared
sites sites sites
L. F.
M. G.
Mercury bichloride
aq. sol.:
o%
Hoo%
3jee%
ilooe%
Potassium dichro-
mate aq. sol.:
Ho%
j45%
3425%
?7425%
++
+
0
0
+
0
0
0
+++
+
0
0
++
0
0
0
+++
++
++
0
++
0
0
0
TABLE III
Reactions to patch tests epplied 48 hours after
intracuteneous injections of autologous
white blood cells
48-Hour Patch Test
Reading
Concentrations
of Allergens WBC
injected
sites
Plasma
injected
sites
Unpre-
paced
sites
Formalin aq. sol.:
3%
2%
1%
iio%
Paraphenylenedi-
amine in Pe-
trolatum:
1%
340%
1/0//4/0
more pronounced as compared with the unpre-
pared control sites. In two subjects, a delayed
reaction was noted after 48 hours at all sites
injected with autologous white blood cells. In
none of the subjects did the patch tests at cell
injected sites produce stronger reactions than
at plasma injected or unprepared sites. In only
one subject (J. G.) did dilutions elicit reactions
at the cell injected sites which produced no
reaction at the control sites. Readings at 72 hours
did not show appreciable changes in reactions.
In two patients the patch tests were applied
M. C.
D. W.
J. M.
J. C.
M. Z.
++
+
0
0
+
0
0
0
++
+
0
0
++
+
0
0
+
0
0
0
+++
+
0
0
+
0
0
0
++
+
0
0
++
+
0
0
+
0
0
0
+++
+++
++
++
+++
+++
++
+
+++
++
+
0
++
0
0
0
++
++
+
0
Formalin aq. sol.:
1%
340%
345%
34%
Potassium dichro-
mate aq. sol.:
345%
3425%
3425%
Resorcin aq. sol.:
3%
2%
1%
34%
ECZEMATOUS CONTACT-TYPE SENSITIVITY IN MAN 109
TABLE IV
Reactions to patch tests applied 72 hours after
intracutaneous injections of au tologous
white blood cells
Concentrations
of Allergens
48-Hour Patch Test
Reading
WBC Plasma Unpce-
injected injected paced
sites sites sites
P. B.
M. G.
Potassium dichro-
mate aq. sol.:
3-%
Ho%5%
)'125%
Nickel sulfate aq.
so!.:
10%
5%
2%
1%
++
++
+
0
+++
+++
++
+
+++
++
++
0
+++
+++
+++
+
+++
+++
++
+
+++
+++
+++
++
24 hours after the intracutaneous injections with
autologous white blood cells. The results are
shown in Table II. Again the reactions at the
cell injected sites were somewhat weaker than
at the control sites. Similar findings were noted
in cell injected sites patch tested after 48 hours
(Table III) and after 72 hours (Table IV).
DISCUSSION
These studies were undertaken to investigate
whether the intracutaneous injection of autol-
ogous white cells in persons with existing strong
allergic contact sensitivities brings about an
increase in specific allergic reactivity at the site
of injection.
The results demonstrate that there was no
augmentation of cutaneous sensitivity to the
homologous allergens. On the contrary, in many
of the test subjects the patch test responses were
weaker at sites injected with autologous white
blood cells than at plasma injected and unpre-
pared control sites. A non-specific interference
with the eczematous response due to the trau-
matic effect produced by the injected cells appears
to be the most likely explanation, particularly
since the reactions at plasma-injected sites also
were frequently weaker than at entirely unpre-
pared sites. It is possible that any reaction-
augmenting effect which might have occurred
due to a specific factor present in the autologous
white cells wa masked by this interference.
It should be noted that the quantity of white
blood cells injected per site in our studies was
much smaller than that used in the previously
cited attempts to passively transfer allergic ec-
zematous sensitivity in man. This is due to dif-
ferences in quantities of blood drawn and in the
technics used for separation of the white blood
cells.
In two patients a delayed reaction was noted
at all sites injected with autologous white blood
cells. These reactions correspond to those de-
scribed by Friedman et al (13) and made it im-
possible to evaluate the patch test responses in
these particular individuals. In view of the ob-
servations of Tromovitch and March (14) it is
of interest that these two patients had a history
of arthralgia.
SUMMARY
Studies are reported on the effects of intra-
cutaneous injection of autologous white blood
cells on contact sensitivity in patients with
strong eczematous allergies. No local increase in
contact sensitivity was observed at the cell-
injected sites. On the contrary in many of the
patients the patch test responses were weaker
at the cell-injected sites than at control sites.
This is attributed to a non-specific interference
produced by the traumatic effect of the cell
injections.
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